René Adam

TL;DR: The results of the largest reported transplant series in the treatment of HEHE are excellent and LT should be offered as a valid therapy earlier in the disease course of these, frequently young, patients.

TL;DR: If the hypothesis is correct that mTOR inhibition can reduce HCC tumour growth while simultaneously providing immunosuppression to protect the liver allograft from rejection, patients should experience less post-transplant problems with HCC recurrence, and therefore could expect a longer and better quality of life.

TL;DR: IVC resection and reconstruction combined with liver resection can be safely performed in selected patients, provided that surgery is carried out at a center specialized in both liver surgery and liver transplantation.

TL;DR: A comprehensive model to predict outcome after liver transplantation, with a novel focus on the impact of the presence of steatosis in the graft, found that microsteatosis, regardless of the amount, was associated with a similar relationship between mortality and BAR score as nonsteatotic livers.

TL;DR: A new staging system is needed that acknowledges both the improvements that have been made in surgical techniques for resectable metastases and the impact of modern chemotherapy on rendering initially unresectable CRC liver metastases resectables, while at the same time distinguishing between patients with a chance of cure at presentation and those for whom only palliative treatment is possible.